Stay updated on XEN1101 Safety/Tolerability/PK in Single/Multiple Ascending Doses Clinical Trial
Sign up to get notified when there's something new on the XEN1101 Safety/Tolerability/PK in Single/Multiple Ascending Doses Clinical Trial page.

Latest updates to the XEN1101 Safety/Tolerability/PK in Single/Multiple Ascending Doses Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe record history now shows a new release revision, v3.6.4, replacing the previous v3.6.3. It reflects a maintenance update to the ClinicalTrials.gov interface rather than changes to the study content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedA new revision entry for v3.6.3 was added to the Study Record History, and the previous v3.6.2 entry was removed. This updates the revision log to reflect the latest administrative update to the record.SummaryDifference0.1%

- Check37 days agoChange DetectedA new version entry v3.6.2 is added to the study record history, and the older v3.6.0 entry is removed from the history view, reflecting a software revision in the page's history.SummaryDifference0.1%

- Check52 days agoChange DetectedRecruitment status updated to cease participant enrollment. A new release version v3.6.0 was added to the history, replacing the previous v3.5.5 entry.SummaryDifference0.4%

- Check59 days agoChange DetectedA new revision entry labeled 'Revision: v3.5.5' was added to the study history, and the previous revision 'Revision: v3.5.4' was removed from the history, indicating an update to the record.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision: v3.5.4 was added, replacing Revision: v3.5.3. This indicates a new release version for the page’s history view.SummaryDifference0.1%

Stay in the know with updates to XEN1101 Safety/Tolerability/PK in Single/Multiple Ascending Doses Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN1101 Safety/Tolerability/PK in Single/Multiple Ascending Doses Clinical Trial page.